# A Study of GZR4 Injection at Different Injection Sites

> **NCT06548906** · PHASE1 · RECRUITING · sponsor: **Gan and Lee Pharmaceuticals, USA** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** GZR4 Injection

## Key facts

- **NCT ID:** NCT06548906
- **Lead sponsor:** Gan and Lee Pharmaceuticals, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-08
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06548906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06548906, "A Study of GZR4 Injection at Different Injection Sites". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06548906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*